Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
41.7%
% of PPH's 27 holdings also in MEDX
33.3%
% of MEDX's 30 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.4% | 16.4% | 12.4% |
|
ABBVIE INC | 5.9% | 8.2% | 5.9% |
|
BRISTOL-MYERS SQUIBB CO | 5.7% | 6.1% | 5.7% |
 |
NOVARTIS AG-ADR | 4.7% | 5.8% | 4.7% |
|
JOHNSON & JOHNSON | 6.4% | 4.6% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to MEDX
 |
NOVO-NORDISK A/S-SPONS ADR | 8.1% |
|
MCKESSON CORP | 5.6% |
|
AMERISOURCEBERGEN CORP | 4.9% |
|
ZOETIS INC | 4.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.5% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
 |
TEVA PHARMACEUTICAL-SP ADR | 3.6% |
|
VIATRIS, INC. | 1.9% |
|
JOHNSON & JOHNSON | 1.8% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 1.5% |
PPH Underweight Relative to MEDX
|
AMGEN INC | -5.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.4% |
 |
ALKERMES PLC | -4.3% |
|
ELI LILLY & CO | -4.0% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
BIOGEN IDEC INC | -2.9% |
|
CRISPR THERAPEUTICS AG | -2.9% |
|
IONIS PHARMACEUTICALS, INC. | -2.8% |
|
ABBVIE INC | -2.3% |
|
BEAM THERAPEUTICS, INC. | -1.7% |